Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 8;10(2):143-154.
doi: 10.5194/jbji-10-143-2025. eCollection 2025.

Oral tetracyclines for bone and joint infections: what do we know?

Tom Cartau  1   2   1   2 , Jocelyn Michon  1   2   1   2 , Renaud Verdon  1   2   3   4   1   2   3   4 , Aurelie Baldolli  1   2   1   2
Affiliations
Review

Oral tetracyclines for bone and joint infections: what do we know?

Tom Cartau et al. J Bone Jt Infect. .

Abstract

Background and aim: Complex bone and joint infections (BJIs), including prosthetic joint infections (PJIs) and infections associated with osteosynthetic materials, present significant treatment challenges that often require surgical intervention and prolonged antibiotic therapy. In France, the incidence of PJIs in knee and hip arthroplasties ranges from 0.79 % to 2.4 %, with staphylococci being the primary pathogens involved. Recent studies have suggested that oral antibiotic therapy may be as effective as intravenous therapy and that 12 weeks of antibiotic treatment are needed. Tetracyclines, particularly doxycycline and minocycline, are of interest because of their broad-spectrum activities, good oral bioavailability, and potential efficacy in treating BJIs. We aimed to provide a literature review on the role of oral tetracyclines in the management of BJIs. Method: We performed a systematic review of the literature identified via an electronic search of PubMed and ScienceDirect. Results: A total of 648 articles were screened, and 31 studies were included. Pharmacological studies demonstrated that the bone to blood penetration ratio ranged from 0.06 to 0.75. Less than 20 % of strains implicated in BJIs exhibited resistance to oral tetracyclines. Four studies demonstrated potential inhibition of strain growth. Eight studies that included 62 patients reported curative treatment, with a success rate ranging from 82 % to 100 % for PJIs regardless of the surgical management. For suppressive therapy, 10 studies that included 201 patients reported success rates ranging from 57 % to 100 %. The rate of adverse effects ranged from 0 % to 14 % for curative treatment and from 0 % to 57 % for suppressive treatment, leading to treatment discontinuation in less than 20 % of cases. Conclusion: This review highlights that the number of studies supporting the use of oral tetracyclines for the treatment of BJIs is limited. More robust pharmacological and clinical studies are needed to confirm the safety and efficacy profiles of oral tetracyclines for the treatment of BJIs.

PubMed Disclaimer

Conflict of interest statement

The contact author has declared that none of the authors has any competing interests.

Figures

Figure 1
Figure 1
Flowchart of the selection process of the 31 studies included in this review on oral tetracycline use for bone and joint infections.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Agwuh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemoth. 2006;58:256–265. doi: 10.1093/jac/dkl224. - DOI - PubMed
    1. Ariza J, Cobo J, Baraia-Etxaburu J, Benito N, Bori G, Cabo J, Corona P, Esteban J, Horcajada JP, Lora-Tamayo J, Murillo O, Palomino J, Parra J, Pigrau C, Del Pozo JL, Riera M, Rodríguez D, Sánchez-Somolinos M, Soriano A, Del Toro MD, De La Torre B. Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) Enferm Infec Micr Cl. 2017;35:189–195. doi: 10.1016/j.eimc.2016.08.012. - DOI - PubMed
    1. Astagneau P. Rapport national de la surveillance semi-automatisée des infections du site opératoire en chirurgie – Données 2020 et 2021. [last access: 3 April 2025]. 2023. https://www.cpias-ile-de-france.fr/spicmi/surveillance/Rapport_2020_2021....
    1. Bahrami F, Morris DL, Pourgholami MH. Tetracyclines: drugs with huge therapeutic potential. Mini-Rev Med Chem. 2012;12:44–52. doi: 10.2174/138955712798868977. - DOI - PubMed
    1. Bart G, Zeller V, Kerroumi Y, Heym B, Meyssonnier V, Desplaces N, Kitzis MD, Ziza JM, Marmor S. Minocycline Combined with Vancomycin for the Treatment of Methicillin-Resistant Coagulase-Negative Staphylococcal Prosthetic Joint Infection Managed with Exchange Arthroplasty. J Bone Joint Infect. 2020;5:110–117. doi: 10.7150/jbji.43254. - DOI - PMC - PubMed

LinkOut - more resources